Basics Cogent Biosciences, Inc. IPO Date: March 26, 2018 Sector: Healthcare Industry: Biotech Market Cap: $638.73M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 3.26% Avg Daily Range (30 D): $0.22 | 4.12% Avg Daily Range (90 D): $0.24 | 3.95% Institutional Daily Volume Avg Daily Volume: .53M Avg Daily Volume (30 D): 1.24M Avg Daily Volume (90 D): 1.17M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 107 Avg Trade Size (Sh.) (90 D): 105 Institutional Trades Total Inst.Trades: 1,484 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $1.02M Avg Inst. Trade (90 D): $1.39M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.7M Avg Closing Trade (30 D): $.8M Avg Closing Trade (90 D): $1.05M Avg Closing Volume: 182.25K     News Apr 15, 2025 @ 5:00 PM Gastrointestinal Stromal Tumor Market to Grow Rapi... Source: Delveinsight Jun 28, 2024 @ 1:18 PM Cogent (COGT) Up on SUMMIT Study Update Post Posit... Source: Zacks Equity Research Jun 14, 2024 @ 11:30 AM Cogent Biosciences Announces Additional Clinical D... Source: Cogent Biosciences, Inc. May 23, 2024 @ 9:05 PM Cogent Biosciences Appoints Cole Pinnow as Chief C... Source: Cogent Biosciences, Inc. May 23, 2024 @ 9:01 PM Cogent Biosciences Announces Positive Updated Lead... Source: Cogent Biosciences, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.84 $-.52 $-.09 Diluted EPS $-1.84 $-.52 $-.09 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -269.5M $ -71.99M $ -67.93M Operating Income / Loss $ -288.47M $ -74.93M $ -73.73M Cost of Revenue $ $ $ Net Cash Flow $ -89.8M $ 27.84M $ 1.12M PE Ratio     Splits Nov 09, 2020:   1:4